V-ensure Pharma Technologies

Began in early 2010 with an aim to redefine the purpose of Contract Research and Dossier Development. This belief helped V-Ensure in achieving exceptional growth by value and volume. A less than 5 years of time and we have offered more than 25 projects developed in-house for the US territory and more than 35 projects for the EU, Canada and Australia market. V-Ensure is constantly evolving in the in-house developments of molecules under 505(b)2 and non-infringing technologies. V-Ensure Pharma Technologies is a belief that grows along with Scientific Character, Innovations and Partnership Approach. We are a set of ideology that denotes an integrated business approach ensuring Contract Research with Cost Efficiency. A development partner whose core competency lies in the areas of Scientific Team Leadership, Patent IP Landscape and constant involvement in the development of Complex Generics, Path-breaking Formulation Strategies in Para IV filings and Regulatory Outlook of the global advanced market. The richness in the talent pool at V-Ensure are nurtured constantly. Our success ratio of fast-track developments and early submissions are a reflection of the Talent Pool. Employees can aim to their aspirations at V-Ensure and have freedom to operate with high level of exposure at various stages of developments for the global advanced markets. The research is carried out with a highly efficient ratio of 1:3.4 scientists into Formulation Development versus Analytical Development & Quality Assurance with over 85 employees collectively.